COVID-19 discovery could protect high-risk patients (IMAGE)

University of Virginia Health System

COVID-19 discovery could protect high-risk patients

Caption

“We are hoping this study could spur strong interests for clinical trials to prevent or treat severe viral infections including COVID-19 in diabetic and/or obese individuals using a second-generation insulin sensitizer," said Jie Sun, PhD, of the University of Virginia School of Medicine.

Credit

Photo by Erin Edgerton, University Communications

Usage Restrictions

May be used to accompany news coverage of the COVID-19 discovery. All other uses require express written permission from UVA Health.

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.